The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis

Lie, Ingrid Anne; Wesnes, Kristin; Kvistad, Silje S.; Brouwer, Iman; Wergeland, Stig; Holmøy, Trygve; Midgard, Rune; Bru, Alla Nikolajevna S; Edland, Astrid; Eikeland, Randi; Gosal, Sonia; Harbo, Hanne-Cathrin Flinstad; Kleveland, Grethe; Sørenes, Yvonne; Øksendal, Nina; Barkhof, Frederik; Vrenken, Hugo; Myhr, Kjell-Morten; Bø, Lars; Torkildesen, Øivind
Peer reviewed, Journal article
Published version
Thumbnail
View/Open
URI
https://hdl.handle.net/11250/3043107
Date
2022
Metadata
Show full item record
Collections
Original version
Lie, I. A., Wesnes, K., Kvistad, S. S., Brouwer, I., Wergeland, S., Holmøy, T., Midgard, R., Bru, A. N. S., Edland, A., Eikeland, R., Gosal, S., Harbo, H.- C. F., Kleveland, G., Sørenes, Y., Øksendal, N., Barkhof, F., Vrenken, H., Myhr, K.- M., Bø, L. & Torkildesen, Ø. (2022). The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. Neurology: Neuroimmunology and neuroinflammation, 9 (5).   https://doi.org/10.1212/NXI.0000000000200008
Abstract
The relationship between smoking, long-term brain atrophy, and clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed long-term effects of smoking by evaluating MRI and clinical outcome measures after 10 years in smoking and nonsmoking patients with relapsing-remitting MS (RRMS).
Journal
Neurology: Neuroimmunology and neuroinflammation
Copyright
© 2022 The Author(s)
Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal